| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |